Home›Companies›Biotech & Pharma›AltrixBio

AltrixBio, Inc.

Updated Oct 29, 2026·Latest SEC filing Jun 16, 2025·Suggest an edit

About AltrixBio

AltrixBio is a private company based in Lowell, Massachusetts. It has reported $7,782,862 raised in two offerings on Form D since June 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 30, 2025Jun 16, 2025$1,150,015of $10.0M target20$57,501EquityRule 504, Rule 506(c), 4a5Form D ↗
Mar 8, 2019Jun 13, 2025amended Jun 13, 2025$6,632,847fully sold50$132KConvertible DebtRule 504, Rule 506(c), 4a5Form D/A ↗1 earlier filing
Total, two offerings$7,782,862

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on AltrixBio's Form D filed Jun 16, 2025.

JB
John Brooks
Director
JK
Jeffrey Karp
Director
AT
NB
Nancy Briefs
President and Director

Sources

  1. SECAltrixBio, Inc. Form D, filed Jun 13, 2025
  2. SECAltrixBio, Inc. filing history